● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● With regards to fundamentals, the enterprise value to sales ratio is at 7.47 for the current period. Therefore, the company is undervalued.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● This company will be of major interest to investors in search of a high dividend stock.
Weaknesses
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the past year, analysts have significantly revised downwards their profit estimates.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● The overall consensus opinion of analysts has deteriorated sharply over the past four months.
● Over the past twelve months, analysts' consensus has been significantly revised downwards.
● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.